1. Home
  2. AVDL vs SPNS Comparison

AVDL vs SPNS Comparison

Compare AVDL & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • SPNS
  • Stock Information
  • Founded
  • AVDL 2015
  • SPNS 1982
  • Country
  • AVDL Ireland
  • SPNS Israel
  • Employees
  • AVDL N/A
  • SPNS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • SPNS Computer Software: Prepackaged Software
  • Sector
  • AVDL Health Care
  • SPNS Technology
  • Exchange
  • AVDL Nasdaq
  • SPNS Nasdaq
  • Market Cap
  • AVDL 1.4B
  • SPNS 1.6B
  • IPO Year
  • AVDL 1996
  • SPNS 1992
  • Fundamental
  • Price
  • AVDL $15.66
  • SPNS $43.01
  • Analyst Decision
  • AVDL Strong Buy
  • SPNS Hold
  • Analyst Count
  • AVDL 8
  • SPNS 3
  • Target Price
  • AVDL $20.88
  • SPNS $31.33
  • AVG Volume (30 Days)
  • AVDL 1.5M
  • SPNS 781.3K
  • Earning Date
  • AVDL 11-11-2025
  • SPNS 11-10-2025
  • Dividend Yield
  • AVDL N/A
  • SPNS 1.39%
  • EPS Growth
  • AVDL N/A
  • SPNS N/A
  • EPS
  • AVDL N/A
  • SPNS 1.22
  • Revenue
  • AVDL $221,075,000.00
  • SPNS $549,037,000.00
  • Revenue This Year
  • AVDL $64.56
  • SPNS $8.50
  • Revenue Next Year
  • AVDL $30.60
  • SPNS $6.83
  • P/E Ratio
  • AVDL N/A
  • SPNS $35.28
  • Revenue Growth
  • AVDL 132.35
  • SPNS 3.08
  • 52 Week Low
  • AVDL $6.38
  • SPNS $23.69
  • 52 Week High
  • AVDL $16.66
  • SPNS $43.17
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.57
  • SPNS 83.35
  • Support Level
  • AVDL $14.78
  • SPNS $42.84
  • Resistance Level
  • AVDL $16.04
  • SPNS $43.09
  • Average True Range (ATR)
  • AVDL 0.57
  • SPNS 0.12
  • MACD
  • AVDL -0.11
  • SPNS -0.50
  • Stochastic Oscillator
  • AVDL 79.23
  • SPNS 52.78

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Share on Social Networks: